These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34633515)

  • 1. Clinical Trials in Pericardial Disease: New Paradigm Shift.
    Imazio M
    Curr Cardiol Rep; 2021 Oct; 23(11):170. PubMed ID: 34633515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
    Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
    Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
    Imazio M; Lazaros G; Gattorno M; LeWinter M; Abbate A; Brucato A; Klein A
    Eur Heart J; 2022 Aug; 43(31):2946-2957. PubMed ID: 34528670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
    Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
    J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pericarditis].
    Marques C; Cacoub P
    Rev Prat; 2021 Jan; 71(1):79-83. PubMed ID: 34160952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine for the prevention of recurrent pericarditis.
    Markel G; Imazio M; Brucato A; Adler Y
    Isr Med Assoc J; 2008 Jan; 10(1):69-72. PubMed ID: 18300579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option.
    Gupta M; Kaul S; Velazquez GR; Bandyopadhyay D; Fonarow GC; Klein A; Ghosh RK
    Am J Cardiovasc Drugs; 2022 Jan; 22(1):27-33. PubMed ID: 34008144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis.
    Abadie BQ; Cremer PC
    BioDrugs; 2022 Jul; 36(4):459-472. PubMed ID: 35639340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis.
    Collini V; Andreis A; De Biasio M; De Martino M; Isola M; Croatto N; Lepre V; Cantarini L; Merlo M; Sinagra G; Abbate A; Lazaros G; Brucato A; Klein AL; Imazio M
    Open Heart; 2024 Mar; 11(1):. PubMed ID: 38490715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in medical therapy for pericardial diseases.
    Galluzzo A; Imazio M
    Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):635-643. PubMed ID: 30103638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Developments in the Management of Recurrent Pericarditis.
    Imazio M; Mardigyan V; Andreis A; Franchin L; De Biasio M; Collini V
    Can J Cardiol; 2023 Aug; 39(8):1103-1110. PubMed ID: 37075863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives.
    Thomas GK; Bonaventura A; Vecchié A; van Tassell B; Imazio M; Klein A; Luis SA; Abbate A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):503-510. PubMed ID: 37163222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis.
    Dong T; Klein AL; Wang TKM
    Curr Cardiol Rep; 2023 Sep; 25(9):993-1000. PubMed ID: 37458866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
    Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
    Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment of recurrent pericarditis: safety considerations and future directions.
    Imazio M
    Expert Opin Drug Saf; 2022 Feb; 21(2):183-190. PubMed ID: 34334059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
    Imazio M; Brucato A; Lazaros G; Andreis A; Scarsi M; Klein A; De Ferrari GM; Adler Y
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):625-629. PubMed ID: 32658005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 blockade for the treatment of pericarditis.
    Buckley LF; Viscusi MM; Van Tassell BW; Abbate A
    Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):46-53. PubMed ID: 28633474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in pharmacotherapy for acute and recurrent pericarditis.
    Vecchié A; Del Buono MG; Mauro AG; Cremer PC; Imazio M; Klein AL; Abbate A; Dentali F; Bonaventura A
    Expert Opin Pharmacother; 2022 Apr; 23(6):681-691. PubMed ID: 35311434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rilonacept and Other Interleukin-1 Inhibitors in the Treatment of Recurrent Pericarditis.
    Goel A; Bandyopadhyay D; Malik AH; Gupta R; Frishman WH; Aronow WS
    Cardiol Rev; 2023 Jul-Aug 01; 31(4):225-229. PubMed ID: 36398320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety.
    Correia ETO; Dos Santos Barbetta LM; de Almeida JPCL; Mesquita ET
    J Cardiovasc Pharmacol; 2020 Jul; 76(1):42-49. PubMed ID: 32265370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.